SPARC lists at 20% premium, hold gains

Sun Pharma Advanced Research Company (SPARC), the demerged new drug and delivery systems business of Sun Pharmaceuticals, opened for trading at Rs 87.20 per share, a premium of nearly 20% to its base price of Rs 72.70 per share on the National Stock Exchange (NSE).

The share was trading at Rs 87.20 at 1200 hrs with a total volume of 1.10 million shares.